Man Group plc Makes New Investment in Avantor, Inc. $AVTR

Man Group plc purchased a new stake in Avantor, Inc. (NYSE:AVTR) during the 2nd quarter, HoldingsChannel reports. The fund purchased 990,477 shares of the company’s stock, valued at approximately $9,806,000.

Other large investors have also recently modified their holdings of the company. Private Management Group Inc. increased its stake in shares of Avantor by 50.4% in the 4th quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock valued at $28,156,000 after acquiring an additional 823,572 shares during the last quarter. GSA Capital Partners LLP bought a new position in Avantor during the 2nd quarter worth approximately $800,000. Oppenheimer Asset Management Inc. bought a new position in Avantor during the 2nd quarter worth approximately $805,000. Assenagon Asset Management S.A. grew its holdings in Avantor by 425.0% during the second quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after purchasing an additional 450,801 shares during the period. Finally, Brickwood Asset Management LLP grew its holdings in Avantor by 6,891.9% during the fourth quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock valued at $36,489,000 after purchasing an additional 3,138,504 shares during the period. Institutional investors own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on AVTR shares. Morgan Stanley increased their target price on shares of Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $13.00 price objective on shares of Avantor in a research report on Thursday, July 30th. Evercore set a $10.50 price objective on Avantor in a research note on Monday, July 6th. Finally, Citigroup lifted their target price on Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Two investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $12.00.

Avantor Stock Performance

Shares of AVTR stock opened at $14.60 on Friday. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $15.93. The company’s fifty day simple moving average is $12.12 and its 200-day simple moving average is $9.77. The firm has a market cap of $9.87 billion, a PE ratio of -17.38, a P/E/G ratio of 11.03 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the firm earned $0.24 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts expect that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.